New York
The State Department of Health announced that effective July 1, several drug manufacturers voluntarily withdrew from participation in the Medicaid Drug Rebate Program (MDRP). The Centers for Medicare and Medicaid Services (CMS), in compliance with Social Security Law Sec. 1927 [42 U.S.C. 1396r–8] (a), requires drug manufacturers to participate in the MDRP for their drugs to be eligible for coverage under the Medicaid program. Prescribers and pharmacies are encouraged to assist members with a therapeutically equivalent generic or to obtain a new prescription for an available alternative.
Also in New York, the Board of Pharmacy met on June 26. The agenda included a presentation by the Department of Health's Bureau of Narcotic Enforcement and a discussion of prescription transfers, shared pharmacy services regulations, Legislative matters and board meeting dates/locations.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
